References
- Xu W, Kimelman D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci. 2007;120(Pt 19):3337–44. doi:https://doi.org/10.1242/jcs.013771
- Pokutta S, Weis WI. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu Rev Cell Dev Biol. 2007; 23(1):237–61. doi:https://doi.org/10.1146/annurev.cellbio.22.010305.104241
- Gao C, Chen G, Romero G, Moschos S, Xu X, Hu J. Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling. J Biol Chem. 2014;289(10):7099–108. doi:https://doi.org/10.1074/jbc.M113.532606
- Hannoush RN. Kinetics of Wnt-driven beta-catenin stabilization revealed by quantitative and temporal imaging. PLoS One. 2008;3(10):e3498. doi:https://doi.org/10.1371/journal.pone.0003498
- Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165. doi:https://doi.org/10.1186/s13045-020-00990-3
- Herbst A, Jurinovic V, Krebs S, Thieme SE, Blum H, Göke B, Kolligs FT. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling. BMC Genomics. 2014;15:74. doi:https://doi.org/10.1186/1471-2164-15-74
- Sherwood V. WNT signaling: an emerging mediator of cancer cell metabolism?Mol Cell Biol. 2015;35(1):2–10. doi:https://doi.org/10.1128/MCB.00992-14
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768–80. doi:https://doi.org/10.1038/nrc1189
- Chiara Mentella M, Scaldaferri F, Ricci C, Gasbarrini A, Abele Donato Miggiano G. Cancer and mediterranean diet: a review. Nutrients. 2019;11:2059. doi:https://doi.org/10.3390/nu11092059
- Ramalingum N, Mahomoodally MF. The therapeutic potential of medicinal foods. Adv Pharmacol Sci. 2014;2014:354264. doi:https://doi.org/10.1155/2014/354264
- Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol. 2019;10:1614. doi:https://doi.org/10.3389/fphar.2019.01614
- Amiri MS, Joharchi MR. Ethnobotanical knowledge of Apiaceae family in Iran: a review. Avicenna J Phytomedicine. 2016;6(6):621–35. doi:https://doi.org/10.22038/ajp.2016.6696
- Miri A, Monsef-Esfahani HR, Amini M, Amanzadeh Y, Hadjiakhoondi A, Hajiaghaee R, Ebrahimi A. Comparative chemical composition and antioxidant properties of the essential oils and aromatic water from Teucrium persicum Boiss. Iran J Pharm Res. 2012;11(2):573–81. doi:https://doi.org/10.22037/ijpr.2012.1093.
- Monsef-Esf HR, Miri A, Amini M, Amanzadeh Y, Hadjiakhoo A, Hajiaghaee R, Ajani Y. Seasonal variation in the chemical composition, antioxidant activity and total phenolic content of Teucrium persicum Boiss. essential oils. Res J Biol Sci. 2010;5(7):492–8. doi:https://doi.org/10.3923/rjbsci.2010.492.498
- Moghtader M. Chemical composition of the essential oil of Teucrium polium L. from Iran. Am Eurasian J Agric Environ Sci. 2009;5(6):843–6. doi:https://doi.org/10.1002/ffj.1463
- Stankovic MS, Curcic MG, Zizic JB, Topuzovic MD, Solujic SR, Markovic SD. Teucrium plant species as natural sources of novel anticancer compounds: antiproliferative, proapoptotic and antioxidant properties. Int J Mol Sci. 2011;12(7):4190–205. doi:https://doi.org/10.3390/ijms12074190
- Ulubelen A, Topçu G, Sönmez U. Chemical and biological evaluation of genus Teucrium. Stud Nat Prod Chem. 2000;23:591–648. doi:https://doi.org/10.1016/S1572-5995(00)80139-8
- Kandouz M, Alachkar A, Zhang L, Dekhil H, Chehna F, Yasmeen A, Al Moustafa A-E. Teucrium polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the E-cadherin/Catenin complex. J Ethnopharmacol. 2010;129(3):410–5. doi:https://doi.org/10.1016/j.jep.2009.10.035
- Afifi FU, Al-Khalidi B, Khalil E. Studies on the in vivo hypoglycemic activities of two medicinal plants used in the treatment of diabetes in Jordanian traditional medicine following intranasal administration. J Ethnopharmacol. 2005;100(3):314–8. doi:https://doi.org/10.1016/j.jep.2005.03.016
- Esmaeili MA, Yazdanparast R. Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets. J Ethnopharmacol. 2004;95(1):27–30. doi:https://doi.org/10.1016/j.jep.2004.06.023
- Gharaibeh MN, Elayan HH, Salhab AS. Hypoglycemic effects of Teucrium polium. J Ethnopharmacol. 1988;24(1):93–9. doi:https://doi.org/10.1016/0378-8741(88)90139-0
- Abdollahi M, Karimpour H, Monsef-Esfehani HR. Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test. Pharmacol Res. 2003; 48(1):31–5. doi:https://doi.org/10.1016/S1043-6618(03)00059-8
- Menichini F, Conforti F, Rigano D, Formisano C, Piozzi F, Senatore F. Phytochemical composition, anti-inflammatory and antitumour activities of four Teucrium essential oils from Greece. Food Chem. 2009;115(2):679–86. doi:https://doi.org/10.1016/j.foodchem.2008.12.067
- Suleiman MS, Abdul-Ghani AS, Al-Khalil S, Amin R. Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure. J Ethnopharmacol. 1988;22(1):111–6. doi:https://doi.org/10.1016/0378-8741(88)90236-X
- Abadian K, Keshavarz Z, Mojab F, Bromand N. The biological effects of Teucrium polium on the severity of primary dysmenorrhea. J Appl Biotechnol Rep. 2016;3(3):453–6.
- Hasani P, Yasa N, Vosough-Ghanbari S, Mohammadirad A, Dehghan GR, Abdollahi M. In vivo antioxidant potential of Teucrium polium, as compared to alpha-tocopherol. Acta Pharm. 2007;57(1):123–9. doi:https://doi.org/10.2478/v10007-007-0010-z
- Movahedi A, Basir R, Rahmat A, Charaffedine M, Othman F. Remarkable anticancer activity of Teucrium polium on hepatocellular carcinogenic rats. Evid Based Complement Alternat Med. 2014;2014:726724. doi:https://doi.org/10.1155/2014/726724
- Miri A, Monsef-Esfahani HR, Amini M, Amanzadeh Y, Hadjiakhoondi A, Hajiaghaee R. Determination of phenolics and flavonoid contents, antioxidant capacity and major flavonoids structure in Teucrium persicum Boiss. J Anim Vet Med. 2011;10(10):258–1261. doi:https://doi.org/10.3923/javaa.2011.1258.1261
- Amirghofran Z, Zand F, Javidnia K, Miri R. The cytotoxic activity of various herbals against different tumor cells: an in vitro study. Iran Red Crescent Med J. 2010;12(3):260–5.
- Miri A, Sharifi-Rad J, Tabrizian K, Nasiri AA. Antinociceptive and anti-inflammatory activities of Teucrium persicum Boiss. extract in mice. Scientifica (Cairo)). 2015;2015:972827. doi:https://doi.org/10.1155/2015/972827
- Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J. PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate. 2011;71(15):1668–79. doi:https://doi.org/10.1002/pros.21383
- Tafrihi M, Toosi S, Minaei T, Gohari AR, Niknam V, Najafi SMA. Anticancer properties of Teucrium persicum in PC-3 prostate cancer cells. Asian Pac J Cancer Prev. 2014;15(2):785–91. doi:https://doi.org/10.7314/APJCP.2014.15.2.785
- Brüser l, Bogdan S. Adherens junctions on the move-membrane trafficking of e-cadherin. Cold Spring Harb Perspect Biol. 2017;9(3):a029140. doi:https://doi.org/10.1101/cshperspect.a029140
- Yu Z, Huang Z, Lung ML. Subcellular fractionation of cultured human cell lines. Bio-Protocol. 2013;3(9):e754. doi:https://doi.org/10.7314/APJCP.2014.15.3.1465
- Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275(5307):1787–90. doi:https://doi.org/10.1126/science.275.5307.1787
- ten Berge D, Koole W, Fuerer C, Fish M, Eroglu E, Nusse R. Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell. 2008;3(5):508–18. doi:https://doi.org/10.1016/j.stem.2008.09.013
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:https://doi.org/10.1016/j.cell.2011.02.013
- Abdullah MZ, Ali JM, Abolmaesoomi M, Abdul-Rahman PS, Hashim OH. Anti-proliferative, in vitro antioxidant, and cellular antioxidant activities of the leaf extracts from Polygonum minus Huds: effects of solvent polarity. Int J Food Prop. 2017;20(sup1):S846–S62. doi:https://doi.org/10.1080/10942912.2017.1315591
- Ashraf MA. Phytochemicals as potential anticancer drugs: time to ponder nature’s bounty. Biomed Res Int. 2020;2020:8602879. doi:https://doi.org/10.1155/2020/8602879
- Kabeer FA, Rajalekshmi DS, Nair MS, Prathapan R. Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells. Integr Med Res. 2017;6:90–206. doi:https://doi.org/10.1016/j.imr.2017.03.004
- Vemuri SK, Banala RR, Subbaiah GPV, Srivastava SK, Reddy AVG, Malarvili T. Anti-cancer potential of a mix of natural extracts of turmeric, ginger and garlic: a cell-based study. Egypt J Basic Appl Sci. 2017; 4(4):332–44. doi:https://doi.org/10.1016/j.ejbas.2017.07.005
- Aissani N, Albouchi F, Sebai H. Anticancer effect in human glioblastoma and antioxidant activity of Petroselinum crispum L. methanol extract. Nutr Cancer. 2020;29:1–9. doi:https://doi.org/10.1080/01635581.2020.1842894
- Ilhan S. Essential oils from Vitex agnus castus L. leaves induces caspase-dependent apoptosis of human multidrug-resistant lung carcinoma cells through intrinsic and extrinsic pathways. Nutr Cancer. 2021;73(4):694–702. doi; doi:https://doi.org/10.1080/01635581.2020.1823439
- Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008;68(6):1820–5. doi:https://doi.org/10.1158/0008-5472.CAN-07-5878
- Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, Chishima T, Shimada H, Moossa AR, Hoffman RM. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 1999;59(4):781–6.
- Zhang K, Waxman DJ. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis. Mol Cancer. 2010;9:319. doi:https://doi.org/10.1186/1476-4598-9-319
- Desai R, Gao L, Raghavan S, Liu WF, Chen CS. Cell polarity triggered by cell-cell adhesion via E-cadherin. J Cell Sci. 2009;122(Pt 7):905–11. doi: https://doi.org/10.1016/j.jep06.023.
- Chen H, Paradies NE, Fedor-Chaiken M, Brackenbury R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci. 1997;110(Pt 3):345–56. doi: https://doi.org/10.1158/0008-5472.CAN-07-5067.
- Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell survival, migration, and invasion by twist: AKT2 comes to interplay. Cancer Res. 2008;68(4):957–60. doi:https://doi.org/10.1158/0008-5472.CAN-07-5067
- Liu T, Lee YN, Malbon CC, Wang HY. Activation of the beta-catenin/Lef-Tcf pathway is obligate for formation of primitive endoderm by mouse F9 totipotent teratocarcinoma cells in response to retinoic acid. J Biol Chem. 2002;277(34):30887–91. doi:https://doi.org/10.1074/jbc.M203852200
- Mahmood MQ, Walters EH, Shukla SD, Weston S, Muller HK, Ward C, Sohal SS. β-catenin, twist and snail: transcriptional regulation of EMT in smokers and COPD, and relation to airflow obstruction. Sci Rep. 2017;7(1):10832. doi:https://doi.org/10.1038/s41598-017-11375-x
- Nowicki A, Sporny S, Duda-Szymańska J. β-catenin as a prognostic factor for prostate cancer (PCa). Cent Eur J Urol. 2012;65(3):119–23. doi:https://doi.org/10.5173/ceju.2012.03.art4
- Bauman TM, Vezina CM, Ricke EA, Halberg RB, Huang W, Peterson RE, Ricke WA. Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression. Hum Pathol. 2016;51:124–33. doi:https://doi.org/10.1016/j.humpath.2015.12.024
- Puig P, Erill N, Terricabras M, Subirana I, González-García J, Asensi-Puig A, Donovan MJ, Mengual L, Agulló-Ortuño MT, Olivan M, et al. Multiple immunofluorescence assay identifies upregulation of active β-catenin in prostate cancer. BMC Res Notes. 2019;12(1):68. doi:https://doi.org/10.1186/s13104-019-4100-z
- Lombardi APG, Vicente CM, Porto CS. Estrogen receptors promote migration, invasion and colony formation of the androgen-independent prostate cancer cells PC-3 through β-catenin pathway. Front Endocrinol (Lausanne)). 2020;11:184. doi:https://doi.org/10.3389/fendo.2020.00184
- Stakheev D, Taborska P, Strizova Z, Podrazil M, Bartunkova J, Smrz D. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. Sci Rep. 2019;9(1):4761. doi:https://doi.org/10.1038/s41598-019-41182-5
- Kumar A, Zloza A, Moon RT, Watts J, Tenorio AR, Al-Harthi L. Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol. 2008;82(6):2813–20. doi:https://doi.org/10.1128/JVI.02498-07
- Shy BR, Wu CI, Khramtsova GF, Zhang JY, Olopade OI, Goss KH, Merrill BJ. Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling. Cell Rep. 2013; 4(1):1–9. doi:https://doi.org/10.1016/j.celrep.2013.06.001
- Ciznadija D, Tothill R, Waterman M, Zhao L, Huynh D, Yu R, Ernst M, Ishii S, Mantamadiotis T, Gonda T, et al. Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling. Cell Death Differ. 2009;16(11):1530–8. doi:https://doi.org/10.1038/cdd.2009.94
- Nakamura Y, de Paiva Alves E, Veenstra GJC, Hoppler S. Tissue- and stage-specific Wnt target gene expression is controlled subsequent to β-catenin recruitment to cis-regulatory modules. Development. 2016;143(11):1914–25. doi:https://doi.org/10.1242/dev.131664
- Lin CM, Chen HH, Lin CA, Wu HC, Sheu JJC, Chen HJ. Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling. Sci Rep. 2017;7(1):372. doi:https://doi.org/10.1038/s41598-017-00409-z
- Dashwood WM, Orner GA, Dashwood RH. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun. 2002;296(3):584–8. doi:https://doi.org/10.1016/S0006-291X(02)00914-2
- Lee W, Yun JM. Suppression of β-catenin signaling pathway in human prostate cancer PC3 cells by delphinidin. J Cancer Prev. 2016;21(2):110–4. doi:https://doi.org/10.15430/JCP.2016.21.2.110
- Khodaei F, Ahmadi K, Kiyani H, Hashemitabar M, Rezaei M. Mitochondrial effects of Teucrium Polium and Prosopis Farcta Extracts in colorectal cancer cells. Asian Pac J Cancer Prev. 2018;19(1):103–9. doi:https://doi.org/10.22034/APJCP.2018.19.1.103
- Nikodijević D, Milutinović M, Cvetković D, Stanković M, Živanović MN, Marković S. Effects of Teucrium polium L. and Teucrium montanum L. extracts on mechanisms of apoptosis in breast and colon cancer cells. Kragujevac J Sci. 2016;38(38):147–59. doi:https://doi.org/10.5937/KgJSci1638147N
- Javidnia K, Miri R, Khosravi AR. Composition of the essential oil of Teucrium persicum Boiss. from Iran. J Essent Oil Res. 2007;19(5):430–2. doi:https://doi.org/10.1080/10412905.2007.9699944
- Sun XB, Wang SM, Li T, Yang YQ. Anticancer activity of linalool terpenoid: apoptosis induction and cell cycle arrest in prostate cancer cells. Trop J Pharm Res. 2015;14(4):619–25. doi:https://doi.org/10.4314/tjpr.v14i4.9
- Zhao Y, Cheng X, Wang G, Liao Y, Qing C. Linalool inhibits 22Rv1 prostate cancer cell proliferation and induces apoptosis. Oncol Lett. 2020;20(6):289. doi:https://doi.org/10.3892/ol.2020.12152
- Zhao Y, Chen R, Wang Y, Yang Y. α-pinene inhibits human prostate cancer growth in a mouse xenograft model. Chemotherapy. 2018;63(1):1–7. doi:https://doi.org/10.1159/000479863
- Jo H, Cha B, Kim H, Brito S, Kwak BM, Kim ST, Bin BH, Lee MG. α-pinene enhances the anticancer activity of natural killer cells via ERK/AKT pathway. Int J Mol Sci. 2021;22(2):656. doi:https://doi.org/10.3390/ijms22020656
- Wang D, Wise ML, Li F, Dey M. Phytochemicals attenuating aberrant activation of β-catenin in cancer cells. PLoS One. 2012;7(12):e50508. doi:10.1371/ journal.pone.0050508.
- Fuentes RG, Toume K, Arai MA, Sadhu SK, Ahmed F, Ishibashi M. Scopadulciol, isolated from Scoparia dulcis, induces β-catenin degradation and overcomes tumor necrosis factor-related apoptosis ligand resistance in AGS human gastric adenocarcinoma cells. J Nat Prod. 2015;78(4):864–72. doi:https://doi.org/10.1021/np500933v
- Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis?Mol Oncol. 2017;11(7):755–69. doi:https://doi.org/10.1002/1878-0261.12083
- Kim DH, Xing T, Yang Z, Dudek R, Lu Q, Chen YH. Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview. J Clin Med. 2018;7(1):1. doi:https://doi.org/10.3390/jcm7010001
- Chang YW, Su YJ, Hsiao M, Wei KC, Lin WH, Liang CJ, Chen SC, Lee JL. Diverse targets of β-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse. Cancer Res. 2015;75(16):3398–410. doi:https://doi.org/10.1158/0008-5472.CAN-14-3265